ArticleAsian Pacific journal of cancer prevention : APJCP2021

Development of Escherichia coli asparaginase II for the Treatment of Acute Lymphocytic Leukemia: In Silico Reduction of asparaginase II Side Effects by a Novel Mutant (V27F).

Noeman Ardalan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.